Guardian Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,687
| Closed | -$1.28M | – | 174 |
|
|
2021
Q4 | $1.28M | Sell |
1,687
-149
| -8% | -$113K | 0.02% | 128 |
|
|
2021
Q3 | $1.37M | Buy |
1,836
+168
| +10% | +$125K | 0.03% | 130 |
|
|
2021
Q2 | $1.08M | Sell |
1,668
-415
| -20% | -$267K | 0.02% | 136 |
|
|
2021
Q1 | $1.19M | Buy |
2,083
+74
| +4% | +$42.3K | 0.02% | 132 |
|
|
2020
Q4 | $1.17M | Buy |
2,009
+12
| +0.6% | +$7K | 0.03% | 124 |
|
|
2020
Q3 | $1.03M | Buy |
1,997
+336
| +20% | +$173K | 0.03% | 119 |
|
|
2020
Q2 | $750K | Sell |
1,661
-685
| -29% | -$309K | 0.02% | 122 |
|
|
2020
Q1 | $822K | Buy |
2,346
+232
| +11% | +$81.3K | 0.02% | 106 |
|
|
2019
Q4 | $782K | Buy |
2,114
+194
| +10% | +$71.8K | 0.02% | 116 |
|
|
2019
Q3 | $639K | Buy |
+1,920
| New | +$639K | 0.01% | 125 |
|